Single therapeutic and supratherapeutic doses of corifollitropin alfa, a sustained follicle stimulant, do not prolong the QTcF-interval in healthy postmenopausal volunteers.

First published in Int. Journal of Clinical Pharmacology and Therapeutics on 2015 Sep.Int J Clin Pharmacol Ther. 2015 Sep;53(9):772-82. doi:...
Read Article